Claudio Hetz

Claudio Hetz received his A.B. in Biotechnology Engineering from the University of Chile in 2000. In his Ph.D. work with Claudio Soto at Serono Pharmaceutical Research Institute, Geneva, he showed that Prion pathogenesis involves endoplasmic reticulum stress responses. In 2004 he joined Stanley Korsmeyer’s lab at Dana-Farber Cancer Institute as a postdoctoral fellow and then followed his projects in Laurie Glimcher’s lab at Harvard. During this period he expanded his studies on neurodegeneration, addressing the connection between apoptosis and the unfolded protein response in vivo. Since 2007 he is an Assistant Professor at the University of Chile and adjunct professor at Harvard.

His lab uses animal models to investigate the signaling responses involved in protein misfolding disorders. He was recently awarded with the TWAS-ROLAC Young Scientist Prize from the Latin-American Science Academy for the best young scientist in the region and the Caribbean, was finalist in the Eppendof and Science Award in Neurobiology and received the Cell Biology Society and “Bios-Chile” prize as the best young scientist of Chile. After that, he was selected from the Ministry of Economy of Chile as one of the successful stories in innovation and Science in Chile, selected by the Latin-American Science Academy to represent Chile in the IAP Young Scientists Conference organized in conjunction with the World Economic Forum in China and receive the prize Young investigator Awards, North American Spine Society, USA. In 2012, awarded with a gift from the Christopher Reeve Spinal Cord Injury and Paralysis Foundation, USA. And Awarded with the FEBS Anniversary Prize of the Gesellschaft für Biochemie und Molekularbiologie. IUBMB & FEBS meeting, Sevilla. His last prize, in 2014 was selected by the LatinAmericanScience.Org and Qué Pasa magazine as one of the 30 more influencing scientist in Latin America.

See our website http://www.hetzlab.cl/